01 June 2020
Visiongain has launched a new report Constipation Nutraceuticals Market Report 2020-2030: Forecasts by Segment (Fibers & Specialty Carbohydrates, Vitamins, Minerals, Carotenoids, Omega-3 Fatty Acids, Prebiotics & Probiotics, Amino Acids & Proteins, Others); by Form (Dry Form and Liquid Form). Plus Financial Analysis of Leading Companies and Regional and Leading National Market Analysis.
Visiongain has forecasted that the global constipation nutraceuticals market will see a revenue of $xyz billion in 2020. Nutraceuticals are the products that provide medicinal and health benefits to the people. These products provide additional nutritional value to the foodstuff. Since 1990’s, there has been a considerable shift in the preference among the consumers towards consumption of nutraceuticals. Presently, the population segment prefers consumption of nutraceuticals as they help to reduce the expensive and high-tech disease treatment. Constipation Nutraceuticals are primarily used in dietary supplements, functional food and beverages as they have natural properties that are essential for disease prevention, and health promotion. Currently, majority of the population segment are aware about their health and believe that proper intake of nutrition can prevent the occurrence of chronic diseases. Nutraceuticals are not only consumed to maintain the dietary allowance but to enhance the performance and prevent diseases. Thus, nutraceuticals as a term is referred to food and food products that after consumption can provide incremental health benefits.
To access the data contained in this document please email email@example.com
The global constipation nutraceuticals market is rising majorly due to increasing geriatric population, rising prevalence of chronic diseases, growing obese population and increasing health awareness. However, high cost of the products and availability of the products are some of the factors that might restrict the growth of the market to some extent during the study period.
On the basis of segment, fibers & specialty carbohydrates segment dominated the global constipation nutraceuticals market in 2020. The dominance of this market segment was majorly due to increasing preference among the population for healthy and nutritional food. Prebiotics and probiotics market segment is estimated to be the most lucrative market during the forecast period from 2020-2030. The growth in this market segment was majorly due to advantages of these products on gut health and increasing application areas, collectively all these factors support the future growth of the prebiotics and probiotics market segment during the study period.
On the basis of form, the dry form segment is expected to dominated the global constipation nutraceuticals market. The dominance of this market segment was majorly due to preference among the companies for this form as its helps to maintain the moisture and nutrient value in the products. In addition, it also retains the shelf life of the product.
Geographically, Asia-Pacific region accounted for the largest market share owing to rising demand for healthy and nutritional products, increasing awareness, rising disposable income and changing lifestyle. In addition, increasing population base and rising demand also support the growth of the regional market during the forecast period.
• DuPont de Nemours, Inc.
• Glanbia Plc
• Associated British Foods, Plc
• Ingredion Incorporated
• Tate & Lyle
• Ajinomoto Group
• BASF SE
• Kerry Group
• Cargill, Inc.
• Arla Foods
• Chr. Hansen Holding A/S
Visiongain's global constipation nutraceuticals market report can keep you informed and up to date with the developments in the market, across four different regions: North America, Europe, Asia-Pacific, South America and Middle-East & Africa.
With reference to this report, it details the key investments trend in the global market, subdivided by segment, by form and by regions. Through extensive secondary research and interviews with industry experts, Visiongain has identified a series of market trends that will impact the constipation nutraceuticals market over the forecast timeframe.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Increasing demand for medical products in developing as well developed economies coupled with rising ageing population is expected to open new opportunities for medical device contract manufacturing industry over the forecast period.
01 December 2020
With the growing burden of rare diseases around the world, there has been a rise in the requirement for proper diagnosis as well as full proof treatment positions for various chronic diseases. With increasing awareness regarding symptoms of various terminal illnesses, the diagnosis rates have been improving in developing countries such as China, India, Japan, Brazil, and other southeast Asian countries.
01 December 2020
Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.
30 November 2020
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.